Episurf Medical AB Stock

Equities

EPIS B

SE0003491562

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Stockholm 08:50:57 2024-04-25 am EDT 5-day change 1st Jan Change
0.3745 SEK -6.02% Intraday chart for Episurf Medical AB -47.18% -62.17%
Sales 2024 * 16.44M 1.51M Sales 2025 * 36.71M 3.38M Capitalization 107M 9.81M
Net income 2024 * -70M -6.44M Net income 2025 * -53M -4.88M EV / Sales 2024 * -0.75 x
Net cash position 2024 * 119M 10.95M Net cash position 2025 * 54M 4.97M EV / Sales 2025 * 1.43 x
P/E ratio 2024 *
-2.65 x
P/E ratio 2025 *
-4.12 x
Employees 28
Yield 2024 *
-
Yield 2025 *
-
Free-Float 76.85%
More Fundamentals * Assessed data
Dynamic Chart
1 day+7.70%
1 week-43.64%
Current month-50.80%
1 month-43.71%
3 months-61.76%
6 months-56.16%
Current year-59.75%
More quotes
1 week
0.32
Extreme 0.32
0.73
1 month
0.32
Extreme 0.32
0.88
Current year
0.32
Extreme 0.32
1.23
1 year
0.32
Extreme 0.32
2.10
3 years
0.32
Extreme 0.32
5.91
5 years
0.32
Extreme 0.32
5.91
10 years
0.32
Extreme 0.32
65.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 41 15-12-13
President 41 20-12-31
Director of Finance/CFO 38 16-07-31
Members of the board TitleAgeSince
Director/Board Member 67 17-05-21
Chairman 70 21-04-30
Director/Board Member 62 20-12-31
More insiders
Date Price Change Volume
24-04-25 0.3745 -6.02% 932 498
24-04-24 0.3985 +7.70% 2,619,557
24-04-23 0.37 -7.50% 2,251,063
24-04-22 0.4 -43.66% 7,680,667
24-04-19 0.71 +0.14% 123,838

Delayed Quote Nasdaq Stockholm, April 24, 2024 at 11:29 am EDT

More quotes
Episurf Medical AB is a Sweden-based medical technology company. It is engaged in the development, manufacture and marketing of implants and surgical drilling templates used in the treatment of local cartilage damage in knee joints. The Company’s product portfolio includes the Episealer, and individually customized implant used as a cartilage replacement for early-stage patients; and Epiguide, a drill guide designed to attach to the knee’s surface, as well as related surgical tools. The personalization of implants and instruments is based on magnetic resonance imaging (MRI) and enables less invasive treatment. The process of ordering and creation of patient-specific implants and surgical instruments is covered by software suite, microiFidelity, comprising microiClinic, microiDesign and microiManufacture. The main shareholder of the Company is Serendipity Ixora Fund AB.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. EPIS B Stock